BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

JPMORGAN CHASE & CO's Holding History (CIK: 0000019617)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 918,000 Value ($000) $1,034 Avg Close — Range —
Q3 2025
Shares 4,093,000 Value ($000) $4,045 Avg Close — Range —
Q2 2025
Shares 876,000 Value ($000) $819 Avg Close — Range —
Q4 2024
Shares 2,706,000 Value ($000) $2,318 Avg Close — Range —
Q3 2024
Shares 1,321,000 Value ($000) $1,102 Avg Close — Range —
Q2 2024
Shares 586,000 Value ($000) $472 Avg Close — Range —
Q1 2024
Shares 3,953,000 Value ($000) $3,255 Avg Close — Range —
Q4 2023
Shares 2,256,000 Value ($000) $1,903 Avg Close — Range —
Q3 2023
Shares 2,095,000 Value ($000) $1,590 Avg Close — Range —
Q2 2023
Shares 2,879,000 Value ($000) $1,774 Avg Close — Range —
Q1 2023
Shares 2,629,000 Value ($000) $1,681 Avg Close — Range —
Q4 2022
Shares 929,000 Value ($000) $0 Avg Close — Range —
Q3 2022
Shares 929,000 Value ($000) $387 Avg Close — Range —
Q2 2022
Shares 929,000 Value ($000) $376 Avg Close — Range —
Q1 2022
Shares 1,229,000 Value ($000) $593 Avg Close — Range —